| 1 |
Association of Serum Potassium with All-Cause Mortality in Patients with and without Heart Failure, Chronic Kidney Disease, and/or Diabetes
Allan J. Collins, Bertram Pitt, Nancy L. Reaven et al. · American Journal of Nephrology
Open access |
2017 |
411 |
| 2 |
Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial
Rajiv Agarwal, Patrick Rossignol, Alain Romero et al. · The Lancet
Open access |
15 Sep 2019 |
375 |
| 3 |
Poly(ortho esters): synthesis, characterization, properties and uses
Jorge Heller, John Barr, Steven Y Ng et al. · Advanced Drug Delivery Reviews
Review |
Oct 2002 |
370 |
| 4 |
Microneedle-Based Vaccines
Mark R. Prausnitz, John A. Mikszta, Michel Cormier et al. · Current topics in microbiology and immunology
Book chapterOpen access |
2009 |
314 |
| 5 |
Molecularly engineered poly(ortho ester) microspheres for enhanced delivery of DNA vaccines
Chun Wang, Qing Ge, David Tsai Ting et al. · Nature Materials
|
15 Feb 2004 |
263 |
| 6 |
Development and field testing of a novel patient-reported outcome measure of dysphagia in patients with eosinophilic esophagitis
Evan S. Dellon, A M Irani, Martin Hill et al. · Alimentary Pharmacology & Therapeutics
Open access |
9 Jul 2013 |
174 |
| 7 |
Design of an injectable system based on bioerodible polyanhydride microspheres for sustained drug delivery
Matt J. Kipper, Elizabeth Shen, Amy S. Determan et al. · Biomaterials
|
26 Aug 2002 |
158 |
| 8 |
Recurrent Lower Urinary Tract Infections Have a Detrimental Effect on Patient Quality of Life: a Prospective, Observational Study
Julien Renard, Stefania Ballarini, Teresa Mascarenhas et al. · Infectious Diseases and Therapy
Open access |
17 Dec 2014 |
156 |
| 9 |
NEUROGENIC INFLAMMATION AND MIGRAINE: IMPLICATIONS FOR THE THERAPEUTICS
Stephen J. Peroutka · Molecular Interventions
|
Oct 2005 |
140 |
| 10 |
Maternal Omega-3 Nutrition, Placental Transfer and Fetal Brain Development in Gestational Diabetes and Preeclampsia
Prasad P. Devarshi, Ryan W. Grant, Chioma J. Ikonte et al. · Nutrients
Open access |
18 May 2019 |
132 |
| 11 |
Uric acid is closely linked to vascular nitric oxide activity
Andrew J. Maxwell, Kristen A Bruinsma · Journal of the American College of Cardiology
Open access |
Dec 2001 |
119 |
| 12 |
Research designs for proof-of-concept chronic pain clinical trials: IMMPACT recommendations
Jennifer S. Gewandter et al. · Pain
Open access |
24 May 2014 |
111 |
| 13 |
Hepatotoxic Potential of Therapeutic Oligonucleotides Can Be Predicted from Their Sequence and Modification Pattern
Peter Hagedorn, Victor Yakimov, Søren Ottosen et al. · Nucleic Acid Therapeutics
Open access |
16 Aug 2013 |
104 |
| 14 |
Randomized Clinical Trial of the Iron-Based Phosphate Binder PA21 in Hemodialysis Patients
Rudolf Peter Wuthrich, Michel Chonchol, Adrian Constantin Covic et al. · Clinical Journal of the American Society of Nephrology
Open access |
3 Nov 2012 |
89 |
| 15 |
Significance of endangered and threatened plant natural products in the control of human disease
Mohamed A. Ibrahim, MinKyun Na, Joonseok Oh et al. · Proceedings of the National Academy of Sciences
Open access |
30 Sep 2013 |
87 |
| 16 |
Effective combination of ET-743 and doxorubicin in sarcoma: preclinical studies
Riccardo Riccardi, Daniela Meco, Tina Colombo et al. · Cancer Chemotherapy and Pharmacology
|
Aug 2003 |
76 |
| 17 |
Randomized trial of a medical food for the dietary management of chronic, stable angina
Andrew J. Maxwell, Michael P. Zapien, Greg L. Pearce et al. · Journal of the American College of Cardiology
Open access |
2002 |
73 |
| 18 |
The future of cancer immunotherapy: DNA vaccines leading the way
Aanshi J. Pandya, Yesha B. Shah, Nirjari R. Kothari et al. · Medical Oncology
Open access |
9 Jun 2023 |
70 |
| 19 |
Psychometric validation of the Dysphagia Symptom Questionnaire in patients with eosinophilic esophagitis treated with budesonide oral suspension
Stacie A. Hudgens, Christopher J. Evans, Elaine Phillips et al. · Journal of Patient-Reported Outcomes
Open access |
11 Aug 2017 |
69 |
| 20 |
Iron Deficiency Generates Secondary Thrombocytosis and Platelet Activation in IBD
Stefanie Kulnigg‐Dabsch, Werner Schmid, Stefanie M. Howaldt et al. · Inflammatory Bowel Diseases
Open access |
3 May 2013 |
68 |
| 21 |
Quenching protein dynamics interferes with HIV capsid maturation
Mingzhang Wang, Caitlin M. Quinn, Juan R. Perilla et al. · Nature Communications
Open access |
20 Nov 2017 |
64 |
| 22 |
The new generation of intravenous iron: chemistry, pharmacology, and toxicology of ferric carboxymaltose
Felix Funk, Peter R. Ryle, Camillo Canclini et al. · Arzneimittelforschung
|
21 Dec 2011 |
64 |
| 23 |
Population‐Based Exposure‐Efficacy Modeling of Ustekinumab in Patients With Moderate to Severe Plaque Psoriasis
Honghui Zhou, Chuanpu Hu, Yaowei Zhu et al. · The Journal of Clinical Pharmacology
|
23 Nov 2009 |
64 |
| 24 |
Long-Term Effects of Patiromer for Hyperkalaemia Treatment in Patients with Mild Heart Failure and Diabetic Nephropathy on Angiotensin-Converting Enzymes/Angiotensin Receptor Blockers: Results from AMETHYST-DN
Bertram Pitt, George L. Bakris, Matthew R. Weir et al. · ESC Heart Failure
Open access |
16 May 2018 |
59 |
| 25 |
Evaluation of an Individualized Dose Titration Regimen of Patiromer to Prevent Hyperkalaemia in Patients with Heart Failure and Chronic Kidney Disease
Bertram Pitt, David A. Bushinsky, Dalane W. Kitzman et al. · ESC Heart Failure
Open access |
25 Jan 2018 |
58 |
| 26 |
Safety and Efficacy of Iron(III)-hydroxide Polymaltose Complex
Peter Geisser · Arzneimittelforschung
|
21 Dec 2011 |
58 |
| 27 |
Endothelial Dysfunction in Hypercholesterolemia is Reversed by a Nutritional Product Designed to Enhance Nitric Oxide Activity
Andrew J. Maxwell, Barbara E. Anderson, Michael P. Zapien et al. · Cardiovascular Drugs and Therapy
|
Mar 2000 |
57 |
| 28 |
Patiromer Versus Placebo to Enable Spironolactone Use in Patients with Resistant Hypertension and Chronic Kidney Disease ( AMBER ): Results in the Pre-Specified Subgroup with Heart Failure
Patrick Rossignol, Bryan Williams, Martha R. Mayo et al. · European Journal of Heart Failure
Open access |
25 May 2020 |
54 |
| 29 |
Use of intravenous iron supplementation in chronic kidney disease: an update.
Iain C. Macdougall, Peter Geisser · PubMed
Open access |
2013 |
54 |
| 30 |
Mutations in the rpoB Gene of Rifampin-Resistant Mycobacterium tuberculosis Isolates in Spain and Their Rapid Detection by PCR–Enzyme-Linked Immunosorbent Assay
Lucia Garcia, Mercedes Alonso‐Sanz, María José Rebollo Espinosa et al. · Journal of Clinical Microbiology
Open access |
May 2001 |
54 |
| 31 |
Rationale and Design of the AFFIRM-AHF Trial: A Randomised, Double-Blind, Placebo-Controlled Trial Comparing the Effect of Intravenous Ferric Carboxymaltose on Hospitalisations and Mortality in Iron-Deficient Patients Admitted for Acute Heart Failure
Piotr P. Ponikowski et al. · European Journal of Heart Failure
Open access |
Dec 2019 |
53 |
| 32 |
Identification of clinical and serological factors during induction treatment of lupus nephritis that are associated with renal outcome
Maria Dall’Era, Victoria Levesque, Neil Solomons et al. · Lupus Science & Medicine
Open access |
May 2015 |
53 |
| 33 |
Real-World Evaluation of Patiromer for the Treatment of Hyperkalemia in Hemodialysis Patients
Csaba Pal Kovesdy, Christopher G. Rowan, Ansgar Conrad et al. · Kidney International Reports
Open access |
29 Oct 2018 |
52 |
| 34 |
4-Fluorinated l -lysine analogs as selective i-NOS inhibitors: methodology for introducing fluorine into the lysine side chain
E. Ann Hallinan, Steven W. Kramer, Stephen C. Houdek et al. · Organic & Biomolecular Chemistry
|
2003 |
50 |
| 35 |
A phase 1b single-arm trial of intratumoral oncolytic virus V937 in combination with pembrolizumab in patients with advanced melanoma: results from the CAPRA study
Ann Willman Silk et al. · Cancer Immunology Immunotherapy
Open access |
29 Nov 2022 |
49 |
| 36 |
A Programmatic Approach to Patient Blood Management – Reducing Transfusions and Improving Patient Outcomes
Shannon L. Farmer, Kevin M. Trentino, Axel Hofmann et al. · The Open Anesthesiology Journal
Open access |
27 Aug 2015 |
46 |
| 37 |
Pharmacokinetics, safety and tolerability of intravenous ferric carboxymaltose: a dose-escalation study in volunteers with mild iron-deficiency anaemia
Peter Geisser, José Banké-Bochita · Arzneimittelforschung
|
21 Dec 2011 |
45 |
| 38 |
Traceless Solid-Phase Synthesis of 1,2,4-Triazoles Using a Novel Amine Resin
Scott D. Larsen, Brian A. DiPaolo · Organic Letters
|
22 Sep 2001 |
45 |
| 39 |
Do self-report and medical record comorbidity data predict longitudinal functional capacity and quality of life health outcomes similarly?
Adesuwa B. Olomu, William D. Corser, Manfred Stommel et al. · BMC Health Services Research
Open access |
14 Nov 2012 |
45 |
| 40 |
Comparative Absorption and Bioavailability of Various Chemical Forms of Zinc in Humans: A Narrative Review
Prasad P. Devarshi, Qingqing Mao, Ryan W. Grant et al. · Nutrients
ReviewOpen access |
11 Dec 2024 |
44 |
| 41 |
Structure-based drug design of pyrazinone antithrombotics as selective inhibitors of the tissue factor VIIa complex
Michael S. South, Brenda L. Case, Rhonda S. Wood et al. · Bioorganic & Medicinal Chemistry Letters
Open access |
9 Jun 2003 |
42 |
| 42 |
Dermal, Subdermal, and Systemic Concentrations of Granisetron by Iontophoretic Delivery
Ayyappa Chaturvedula, Dipty P. Joshi, Carter Anderson et al. · Pharmaceutical Research
|
Aug 2005 |
41 |
| 43 |
Patiromer Lowers Serum Potassium When Taken without Food: Comparison to Dosing with Food from an Open-Label, Randomized, Parallel Group Hyperkalemia Study
Pablo E. Pérgola, David M. Spiegel, Suzette Warren et al. · American Journal of Nephrology
Open access |
2017 |
40 |
| 44 |
Pharmacokinetics and Metabolism of a COX-2 Inhibitor, Valdecoxib, in Mice
Ji Y. Zhang, Josh J. Yuan, Yue-Fen Wang et al. · Drug Metabolism and Disposition
|
18 Mar 2003 |
40 |
| 45 |
The risk of medically uncontrolled secondary hyperparathyroidism depends on parathyroid hormone levels at haemodialysis initiation
Nahid Tabibzadeh, Angelo Karaboyas, Bruce Robinson et al. · Nephrology Dialysis Transplantation
Open access |
9 Jul 2020 |
39 |
| 46 |
Intravenous iron and erythropoiesis‐stimulating agents in haemodialysis: A systematic review and meta‐analysis
Simon D. Roger, Martin Tio, Hyeong Cheon Park et al. · Nephrology
ReviewOpen access |
11 Oct 2016 |
39 |
| 47 |
Intravenous iron alone resolves anemia in patients with functional iron deficiency and lymphoid malignancies undergoing chemotherapy
Michael Hedenus, Torbjörn Karlsson, Heinz Ludwig et al. · Medical Oncology
Open access |
5 Nov 2014 |
39 |
| 48 |
Bioerodible injectable poly(ortho ester) for tetracycline controlled delivery to periodontal pockets: Preliminary trial in humans
Khadija Schwach‐Abdellaoui, Pierre‐Jean Loup, N Vivien-Castioni et al. · AAPS PharmSci
Open access |
Dec 2002 |
36 |
| 49 |
Protection against vascular endothelial dysfunction by polyphenols in sea buckthorn berries in rats with hyperlipidemia
Fang Yang, Yourui Suo, Dongli Chen et al. · BioScience Trends
Open access |
2016 |
34 |
| 50 |
Development and validation of a liquid chromatography–tandem mass spectrometric assay for Eplerenone and its hydrolyzed metabolite in human plasma
Ji Y. Zhang, Douglas M. Fast, Alan P. Breau · Journal of Chromatography B
|
25 Mar 2003 |
31 |